- Home
- Publications
- Publication Search
- Publication Details
Title
Drug-Eluting Stents: the Past, Present, and Future
Authors
Keywords
Bare metal stents, Bioresorbable stents, Drug-eluting stents, Percutaneous coronary intervention
Journal
Current Atherosclerosis Reports
Volume 17, Issue 3, Pages -
Publisher
Springer Nature
Online
2015-02-04
DOI
10.1007/s11883-014-0485-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Three-Year Outcomes After Revascularization With Everolimus- and Sirolimus-Eluting Stents From the SORT OUT IV Trial
- (2014) Lisette Okkels Jensen et al. JACC-Cardiovascular Interventions
- Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients With ST Elevation Myocardial Infarction
- (2014) Emilio Di Lorenzo et al. JACC-Cardiovascular Interventions
- Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease
- (2013) Patrick W. Serruys et al. JACC-Cardiovascular Interventions
- Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent
- (2013) Masahiro Natsuaki et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Consideration of a New Definition of Clinically Relevant Myocardial Infarction After Coronary Revascularization
- (2013) Issam D. Moussa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical Outcomes With Drug-Eluting and Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction
- (2013) Tullio Palmerini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical Outcomes With Bioabsorbable Polymer- Versus Durable Polymer-Based Drug-Eluting and Bare-Metal Stents
- (2013) Tullio Palmerini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial
- (2013) Pieter Cornelis Smits et al. LANCET
- Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial
- (2013) Evald Høj Christiansen et al. LANCET
- Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial
- (2013) Clemens von Birgelen et al. LANCET
- Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis
- (2013) E. P. Navarese et al. BMJ-British Medical Journal
- Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis
- (2013) S. Bangalore et al. BMJ-British Medical Journal
- ABSORB II randomized controlled trial
- (2012) Roberto Diletti et al. AMERICAN HEART JOURNAL
- Comparative efficacy of 2 zotarolimus-eluting stent generations: Resolute versus endeavor stents in patients with coronary artery disease
- (2012) Tomohisa Tada et al. AMERICAN HEART JOURNAL
- Longitudinal compression of the platinum-chromium everolimus-eluting stent during coronary implantation: Predisposing mechanical properties, incidence, and predictors in a large patient cohort
- (2012) Gregor Leibundgut et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- Long-Term (>10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly- l -Lactic Acid Coronary Stents
- (2012) Soji Nishio et al. CIRCULATION
- Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents
- (2012) Sripal Bangalore et al. CIRCULATION
- Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents
- (2012) Takeshi Kimura et al. CIRCULATION
- Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated With Percutaneous Coronary Intervention
- (2012) Lisette Okkels Jensen et al. CIRCULATION
- 3-Year Clinical Outcomes in the Randomized SORT OUT III Superiority Trial Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents
- (2012) Michael Maeng et al. JACC-Cardiovascular Interventions
- Primary Endpoint Results of the EVOLVE Trial
- (2012) Ian T. Meredith et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2-Year Patient-Related Versus Stent-Related Outcomes
- (2012) Lisette Okkels Jensen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients
- (2012) Clemens von Birgelen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety and Efficacy of Second-Generation Everolimus-Eluting Xience V Stents Versus Zotarolimus-Eluting Resolute Stents in Real-World Practice
- (2012) Kyung Woo Park et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis
- (2012) Tullio Palmerini et al. LANCET
- Long-Term (Three-Year) Safety and Efficacy of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents (from the SPIRIT III Trial)
- (2011) Robert J. Applegate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Everolimus-Eluting Versus Sirolimus-Eluting Stents
- (2011) Antoinette de Waha et al. Circulation-Cardiovascular Interventions
- Stent Longitudinal Integrity
- (2011) John A. Ormiston et al. JACC-Cardiovascular Interventions
- A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent
- (2011) Gregg W. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents
- (2011) Gregg W. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice
- (2011) Pieter C. Smits et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Long-Term Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents for Coronary Revascularization
- (2011) Lorenz Räber et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Stent Thrombosis
- (2010) David R. Holmes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial
- (2010) Elvin Kedhi et al. LANCET
- Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial
- (2010) Klaus Rasmussen et al. LANCET
- Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease
- (2010) Gregg W. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents
- (2010) Patrick W. Serruys et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial
- (2009) R. A. Byrne et al. EUROPEAN HEART JOURNAL
- Long-Term Clinical and Economic Analysis of the Endeavor Zotarolimus-Eluting Stent Versus the Cypher Sirolimus-Eluting Stent
- (2009) Eric L. Eisenstein et al. JACC-Cardiovascular Interventions
- Long-Term Safety and Efficacy With Paclitaxel-Eluting Stents
- (2009) Stephen G. Ellis et al. JACC-Cardiovascular Interventions
- Five-Year Follow-Up After Sirolimus-Eluting Stent Implantation
- (2009) Giora Weisz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease
- (2008) Gregg W. Stone JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Novel Bioresorbable Polymer Paclitaxel-Eluting Stent for the Treatment of Single and Multivessel Coronary Disease
- (2008) Mitchell W. Krucoff et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started